Psoriasis trials in Belgium

In Belgium 13 Also abroad 274

13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Brugge, Genk, Gent, Liège, Mons
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Gent, Jette, Leuven
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 3Taking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Bruxelles, Gent
Age
40 years and over
People
3,040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Gent, Liège, Sint-Lambrechts-Woluwe
Age
12 years to 17 years
People
366 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00
Phase 2/3Not yet taking people in Belgium
Prospective diagnostic performance of PET/CT using the novel fibroblast imaging tracer [18F]-AlF-FAPI-74 versus power doppler ultrasound in psoriasis patients with arthralgia: early detection of psoriatic arthritis
Where
Edegem, Leuven
Age
18 years and over
People
270
Run by
UZ Leuven
See details and how to join2026-526942-29-00 · EU 2026-526942-29-00
Phase 3Taking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Anderlecht, Brussels, Genk, Gent, Liège
Age
18 years and over
People
1,088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Anderlecht, Brussels, Genk, Gent, Liège
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 4Taking people
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Where
Leuven, Ghent University Hospital
Age
18 years and over
People
100 worldwide
Run by
CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00
No phaseTaking people
Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
Where
Brussels
Age
18 years and over
People
600
Run by
Jonathan Krygier
See details and how to joinNCT07234838
Phase 4Taking people
Proactive TDM Versus Standard Use of Biologics in Psoriasis
Where
Anderlecht, Brugge, Brussels, Eeklo, Geel, Gent, Gerpinnes, Jette, Kortrijk, Leuven, Liège, Maldegem, Sint-Lambrechts-Woluwe
Age
18 years and over
People
210
Run by
University Hospital, Ghent
See details and how to joinNCT06398106 · EU 2023-509637-39-00
No phaseTaking people
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Where
Aalst, Anderlecht, Charleroi, Genk, Leuven, Liège
Age
18 years to 75 years
People
1,200 worldwide
Run by
AbbVie
See details and how to joinNCT06764693
No phaseTaking people
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Where
Brussels
Age
2 years to 50 years
People
1,000
Run by
Université Catholique de Louvain
See details and how to joinNCT07000916
No phaseTaking people
ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
Where
Leuven
Age
12 years to 70 years
People
200
Run by
Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT05122039